Diamedica Therapeutics Inc (DMAC)

Diamedica Therapeutics Inc Azioni (DMAC) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Research and Development	0.03% 3.676	3.677	3.272	2.543	3.618
Operating Income/Loss	1.83% -5.741	-5.848	-5.157	-4.741	-5.521
Income/Loss From Continuing Operations Before Tax	0.10% -5.144	-5.139	-4.464	-4.47	-5.265
Income Tax Expense/Benefit	68.18% 0.007	0.022	0.007	0.007	0.007
Income/Loss From Continuing Operations After Tax	0.19% -5.151	-5.161	-4.471	-4.477	-5.272
Net Income/Loss	0.19% -5.151	-5.161	-4.471	-4.477	-5.272
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,991% 37.96	1.8154	37.95	27.31	26.45
Basic Earnings Per Share	0.00% -0.14	-0.14	-0.12	-0.16	-0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-